Catherine Priest

Biochemistry, Genetics and Molecular Biology · Life Sciences

21h-index2.9kcitations41works2.32yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pluripotent Stem Cells Research(15), Neurogenesis and neuroplasticity mechanisms(7), Neuropeptides and Animal Physiology(7), Regulation of Appetite and Obesity(6), Neuroscience and Neuropharmacology Research(5)

Publications41 total

Human stem cell-derived GABAergic interneuron development reveals early emergence of subtype diversity and gradual electrochemical maturation
Neuron·2025· 4 citedOpen Access
First-in-Human Trial of NRTX-1001 GABAergic Interneuron Cell Therapy for Focal Epilepsy - Updated Clinical Trial Results (P8-9.003)
Neurology·2025· 4 cited
Human stem cell-derived GABAergic interneuron development reveals early emergence of subtype diversity followed by gradual electrochemical maturation
2024· 3 citedOpen Access
Considerations in the development of pluripotent stem cell–based therapies
Elsevier eBooks·2024
Contributors
Elsevier eBooks·2024Open Access
First-in-Human Trial of NRTX-1001 GABAergic Interneuron Cell Therapy for Treatment of Focal Epilepsy - Emerging Clinical Trial Results (S19.002)
Neurology·2024· 5 cited
Human Stem Cell-Derived GABAergic Interneuron Development Reveals Early Emergence of Subtype Diversity Followed by Gradual Electrochemical Maturation
SSRN Electronic Journal·2024Open Access
Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy
Cell stem cell·2023· 59 citedOpen Access
Non-invasive metabolic biomarkers of interneuron cell transplantation therapy in an epilepsy model
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2023
Preclinical Development of NRTX-1001, an Inhibitory Interneuron Cellular Therapeutic for the Treatment of Chronic Focal Epilepsy (S13.007)
Neurology·2022
Cell transplantation to repair the injured spinal cord
International review of neurobiology·2022· 10 citedOpen Access
Safety of direct injection of oligodendrocyte progenitor cells into the spinal cord of uninjured Göttingen minipigs
Journal of Neurosurgery Spine·2021· 6 citedOpen Access
Preclinical Development of Human Inhibitory Interneuron Cell Therapy (NTX-001) for Chronic Focal Epilepsy (2470)
Neurology·2021
Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord Injury
Stem Cells Translational Medicine·2017· 112 citedOpen Access
Preclinical Safety of Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors Supporting Clinical Trials in Spinal Cord Injury
Regenerative Medicine·2015· 117 cited
Proceedings: Moving Toward Cell-Based Therapies for Heart Disease
Stem Cells Translational Medicine·2015· 8 citedOpen Access
Proceedings: Cell Therapies for Parkinson's Disease From Discovery to Clinic
Stem Cells Translational Medicine·2014· 9 citedOpen Access
Proceedings: International Regulatory Considerations on Development Pathways for Cell Therapies
Stem Cells Translational Medicine·2014· 24 citedOpen Access
Efficient Generation and Cryopreservation of Cardiomyocytes Derived from Human Embryonic Stem Cells
Regenerative Medicine·2010· 96 citedOpen Access
Corning® Synthemax™ Surface: a tool for feeder-free, xeno-free culture of human embryonic stem cells
Nature Methods·2010· 10 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Cory R. Nicholas(9), Marina Bershteyn(8), Yves Maury(8), Luis C. Fuentealba(8), Paul E. Micevych(7), Sonja Kriks(6), Seonok Lee(6), Alessandro Bulfone(6), James L. Roberts(5), Jane Lebkowski(5), E. Sevilla(5), Philip Hampel(5), Gautam Banik(5), Brianna G Feld(5), Jihye Jung(5), Tia J. Kowal(5), Charles V. Mobbs(4), Jerrod Denham(4), Mansi Parekh(4), Steven Havlicek(4)